DavidJosRitchieMD

PubMed

• 4 citations
  Evaluation of Total Body Weight versus Adjusted Body Weight Liposomal Amphotericin B Dosing in Obese Patients.
  Michelle H Ting, Andrej Spec, Scott T. Micek, David J. Ritchie, Tamara Krekel> ;Antimicrobial Agents and Chemotherapy. 2021 Aug 17
• 13 citations
  New Perspectives on Antimicrobial Agents: Ceftolozane-Tazobactam.
  Bryan D. Lizza, Kevin D Betthauser, David J. Ritchie, Scott T. Micek, Marin H. Kollef> ;Antimicrobial Agents and Chemotherapy. 2021 Jun 17
• A Cluster of Cefepime-induced Neutropenia during Outpatient Parenteral Antimicrobial Therapy.
  Foong, K. S.,Hsueh, K.,Bailey, T. C.,Luong, L.,Iqbal, A.,Hoehner, C.,Connor, L.,Casabar, E.,Lane, M.,Burnett, Y.,Ritchie, D.,Krekel, T.,Newland, H.,Weilmuenster, L.,He...> ;Clin. Infect. Dis.. 2018 Dec 28
• Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas Aeruginosa Sepsis
  David J Ritchie, Michael J Durkin, Marin H Kollef> ;mBio. 2018 Jan 31
• Telavancin for refractory MRSA bacteraemia in intermittent haemodialysis recipients.
  Britt, N. S.,Tirmizi, S.,Ritchie, D. J.,Topal, J. E.,McManus, D.,Nizet, V.,Casabar, E.,Sakoulas, G.> ;J. Antimicrob. Chemother.. 2017 Dec 16
• A review of intravenous minocycline for treatment of multidrug-resistant acinetobacter infections.
  Ritchie, D. J.,Garavaglia-Wilson, A.> ;Clin. Infect. Dis.. 2014 Nov 06
• Acute renal insufficiency during telavancin therapy in clinical practice.
  Marcos, L.A., Camins, B.C., Ritchie, D.J., Casabar, E., Warren, D.K.> ;J Antimicrob Chemother. 2012 Mar
• Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
  Crank, C.W., Scheetz, M.H., Brielmaier, B., Rose, W.E., Patel, G.P., Ritchie, D.J., Segreti, J.> ;Clin Ther. 2010 Sep
• Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients.
  Alexander, B.T., Hladnik, L.M., Augustin, K.M., Casabar, E., McKinnon, P.S., Reichley, R.M., Ritchie, D.J., Westervelt, P., Dubberke, E.R.> ;Pharmacotherapy. 2010 Jun
• 1 citations
  Disease status at autologous stem cell transplantation and the cell of origin phenotype are important predictors of outcome in patients with neurologic (central nervou...
  Sushrut Patil, Andrew Spencer, Anthony P. Schwarer, Sharon Avery, David Ritchie, Stephen Opat, Andrew H. Wei, Catriona McLean> ;Leukemia & Lymphoma. 2009 Dec 9
• New antimicrobial agents for use in the intensive care unit.
  Ritchie, D.J., Alexander, B.T., Finnegan, P.M.> ;Infect Dis Clin North Am. 2009-09-01
• Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adult...
  Arnold, H.M., McKinnon, P.S., Augustin, K.M., Hladnik, L.M., Casabar, E., Reichley, R.M., Dubberke, E.R., Westervelt, P., Ritchie, D.J.> ;Pharmacotherapy. 2009-08-01
• New antibiotics for healthcare-associated pneumonia.
  Neuner, E.A., Ritchie, D.J., Micek, S.T.> ;Semin Respir Crit Care Med. 2009-02-01
• Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa...
  Deal, E.N., Micek, S.T., Reichley, R.M., Ritchie, D.J.> ;Clin Ther. 2009 Feb
• Early clinical experience with anidulafungin at a large tertiary care medical center.
  Brielmaier, B.D., Casabar, E., Kurtzeborn, C.M., McKinnon, P.S., Ritchie, D.J.> ;Pharmacotherapy. 2008 Jan
• 28 citations
  Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines, angiogenic markers, mast cells and marrow CD57+ cytotoxic T cell...
  Linda Mileshkin, Dirk Hönemann, Peter Gambell, Melanie Trivett, Yoshihiro Hayakawa, Mark J. Smyth, Victoria Beshay, David Ritchie, Paul J. Simmons, Alvin Milner, Jerom...> ;Haematologica. 2007 Aug 1
• Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae.
  Daly, M.W., Riddle, D.J., Ledeboer, N.A., Dunne, W.M., Ritchie, D.J.> ;Pharmacotherapy. 2007 Jul
• Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.
  Deal, E.N., Micek, S.T., Ritchie, D.J., Reichley, R.M., Dunne, W.M., Kollef, M.H.> ;Pharmacotherapy. 2007 Feb
• Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices.
  Jeffres, M.N., Isakow, W., Doherty, J.A., McKinnon, P.S., Ritchie, D.J., Micek, S.T., Kollef, M.H.> ;Chest. 2006 Oct
• A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemia.
  Wilson, A.G., Micek, S.T., Ritchie, D.J.> ;Clin Ther. 2005 Aug
• Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment.
  Micek, S. T.,Lloyd, A. E.,Ritchie, D. J.,Reichley, R. M.,Fraser, V. J.,Kollef, M. H.> ;Antimicrob Agents Chemother. 2005 Apr
• Enterococcus faecalis resistant to linezolid: case series and review of the literature.
  Burleson, B.S., Ritchie, D.J., Micek, S.T., Dunne, W.M.> ;Pharmacotherapy. 2004 Sep
• Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.
  Zervos, M.J., Hershberger, E., Nicolau, D.P., Ritchie, D.J., Blackner, L.K., Coyle, E.A., Donnelly, A.J., Eckel, S.F., Eng, R.K., Hiltz, A., Kuyumjian, A.G., Krebs, W....> ;Clin Infect Dis. 2003 Dec 15
• Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection.
  Qaqish, R.B., Mattes, K.A., Ritchie, D.J.> ;Clin Ther. 2003 Dec
• Enterobacter cloacae ventriculitis successfully treated with cefepime and gentamicin: case report and review of the literature.
  Barnes, B.J., Wiederhold, N.P., Micek, S.T., Polish, L.B., Ritchie, D.J.> ;Pharmacotherapy. 2003 Apr
• Join now to see all